STCube Inc
STCube, Inc., a biopharmaceutical company, develops therapies to treat novel immune evasion mechanisms in cancer in South Korea. Its platforms include STGlyTarget that is used for the identification and development of immunomodulatory proteins; Immunomodulator Discovery Platform, a proprietary technology to screen for immunomodulatory proteins; Glyco-Specific Antibody Development Platform, a tech… Read more
STCube Inc (052020) - Net Assets
Latest net assets as of September 2025: ₩78.59 Billion KRW
Based on the latest financial reports, STCube Inc (052020) has net assets worth ₩78.59 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩94.40 Billion) and total liabilities (₩15.81 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩78.59 Billion |
| % of Total Assets | 83.25% |
| Annual Growth Rate | 12.26% |
| 5-Year Change | 161.69% |
| 10-Year Change | 350.81% |
| Growth Volatility | 77.5 |
STCube Inc - Net Assets Trend (2009–2024)
This chart illustrates how STCube Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for STCube Inc (2009–2024)
The table below shows the annual net assets of STCube Inc from 2009 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩94.28 Billion | +167.01% |
| 2023-12-31 | ₩35.31 Billion | -31.07% |
| 2022-12-31 | ₩51.22 Billion | +216.87% |
| 2021-12-31 | ₩16.16 Billion | -55.13% |
| 2020-12-31 | ₩36.03 Billion | +25.02% |
| 2019-12-31 | ₩28.82 Billion | -25.54% |
| 2018-12-31 | ₩38.70 Billion | +102.40% |
| 2017-12-31 | ₩19.12 Billion | -34.60% |
| 2016-12-31 | ₩29.24 Billion | +39.82% |
| 2015-12-31 | ₩20.91 Billion | -2.56% |
| 2014-12-31 | ₩21.46 Billion | +96.48% |
| 2013-12-31 | ₩10.92 Billion | +24.30% |
| 2012-12-31 | ₩8.79 Billion | -11.88% |
| 2011-12-31 | ₩9.97 Billion | -15.03% |
| 2010-12-31 | ₩11.74 Billion | -29.45% |
| 2009-12-31 | ₩16.63 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to STCube Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 12256857729100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩33.99 Billion | 36.06% |
| Other Components | ₩184.69 Billion | 195.90% |
| Total Equity | ₩94.28 Billion | 100.00% |
STCube Inc Competitors by Market Cap
The table below lists competitors of STCube Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SOUTH PLAINS FINAN. DL 1
F:4S4
|
$443.00 Million |
|
Sgis Songshan Co Ltd
SHE:000717
|
$443.11 Million |
|
34Q0
F:34Q0
|
$443.29 Million |
|
ADC Therapeutics SA
NYSE:ADCT
|
$443.34 Million |
|
Hunan Fangsheng Pharm Co Ltd
SHG:603998
|
$442.92 Million |
|
IntelliEPI Cayman
TWO:4971
|
$442.45 Million |
|
LANXESS Aktiengesellschaft
PINK:LNXSY
|
$442.21 Million |
|
Merida Industry Co Ltd
TW:9914
|
$442.17 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in STCube Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 35,308,187,460 to 94,275,894,290, a change of 58,967,706,830 (167.0%).
- Net loss of 21,436,613,480 reduced equity.
- Share repurchases of 81,357,504,640 reduced equity.
- New share issuances of 81,357,504,640 increased equity.
- Other factors increased equity by 80,404,320,310.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-21.44 Billion | -22.74% |
| Share Repurchases | ₩81.36 Billion | -86.3% |
| Share Issuances | ₩81.36 Billion | +86.3% |
| Other Changes | ₩80.40 Billion | +85.29% |
| Total Change | ₩- | 167.01% |
Book Value vs Market Value Analysis
This analysis compares STCube Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 11.69x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 16.13x to 11.69x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1005.79 | ₩16220.00 | x |
| 2017-12-31 | ₩634.80 | ₩16220.00 | x |
| 2018-12-31 | ₩1279.91 | ₩16220.00 | x |
| 2019-12-31 | ₩937.49 | ₩16220.00 | x |
| 2020-12-31 | ₩1008.25 | ₩16220.00 | x |
| 2021-12-31 | ₩449.67 | ₩16220.00 | x |
| 2022-12-31 | ₩1121.39 | ₩16220.00 | x |
| 2023-12-31 | ₩763.78 | ₩16220.00 | x |
| 2024-12-31 | ₩1387.77 | ₩16220.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently STCube Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -22.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -189.74%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 1.19x
- Recent ROE (-22.74%) is above the historical average (-41.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | -14.65% | -19.78% | 0.62x | 1.20x | ₩-4.10 Billion |
| 2010 | 7.33% | 4.85% | 1.13x | 1.34x | ₩-313.38 Million |
| 2011 | -46.53% | -62.53% | 0.48x | 1.55x | ₩-5.64 Billion |
| 2012 | -17.08% | -13.36% | 0.82x | 1.56x | ₩-2.38 Billion |
| 2015 | -26.31% | -117.10% | 0.20x | 1.12x | ₩-7.59 Billion |
| 2016 | -21.43% | -41.06% | 0.37x | 1.39x | ₩-9.19 Billion |
| 2017 | -86.05% | -194.47% | 0.32x | 1.38x | ₩-18.37 Billion |
| 2018 | -27.66% | -102.26% | 0.18x | 1.51x | ₩-14.58 Billion |
| 2019 | -41.81% | -69.28% | 0.33x | 1.82x | ₩-14.93 Billion |
| 2020 | -44.28% | -157.58% | 0.20x | 1.40x | ₩-19.55 Billion |
| 2021 | -133.19% | -271.64% | 0.31x | 1.60x | ₩-23.15 Billion |
| 2022 | -36.88% | -299.76% | 0.10x | 1.19x | ₩-24.01 Billion |
| 2023 | -69.39% | -420.43% | 0.13x | 1.30x | ₩-28.03 Billion |
| 2024 | -22.74% | -189.74% | 0.10x | 1.19x | ₩-30.86 Billion |
Industry Comparison
This section compares STCube Inc's net assets metrics with peer companies in the Electronic Equipment & Parts industry.
Industry Context
- Industry: Electronic Equipment & Parts
- Average net assets among peers: $88,795,821,277
- Average return on equity (ROE) among peers: -1.03%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| STCube Inc (052020) | ₩78.59 Billion | -14.65% | 0.20x | $442.98 Million |
| SANGBO Corp (027580) | $29.45 Billion | -35.18% | 2.55x | $19.25 Million |
| Inzi Display Co.Ltd (037330) | $162.56 Billion | 1.55% | 0.59x | $19.38 Million |
| BioSmart Co.Ltd (038460) | $58.82 Billion | 5.35% | 0.27x | $46.07 Million |
| e-LITECOM CO. Ltd (041520) | $38.24 Billion | 17.41% | 1.56x | $35.12 Million |
| CoAsia Corporation (045970) | $100.09 Billion | 0.00% | 1.72x | $59.77 Million |
| Powerlogics Co. Ltd (047310) | $212.21 Billion | -3.86% | 1.12x | $121.60 Million |
| Phoenix Materials Co. Ltd (050090) | $27.29 Billion | -7.19% | 0.62x | $8.87 Million |
| CammSys Corp (050110) | $75.36 Billion | 10.73% | 0.88x | $23.68 Million |
| Amotech Co. Ltd (052710) | $95.14 Billion | 1.97% | 1.04x | $55.48 Million |